Chronic liver disease in Europe: A preventable crisis going undetected

Europe is facing a growing chronic liver disease threat, according to a new series published in The Lancet Regional Health—Europe, that engaged more than 75 co-authors from 30 countries and was led by the Barcelona Institute for Global Health (ISGlobal). The Series, "Ending the chronic liver disease public health threat in Europe," warns that Europe must move liver disease beyond hepatology and better integrate it into European health systems.

New maternal RSV vaccine lowers infant hospitalization rates, but accessibility may be limited, study finds

Respiratory syncytial virus (RSV) is a common respiratory virus that can cause severe breathing complications in babies, especially those younger than 6 months old. While many adults recover quickly from RSV with mild symptoms similar to a cold, infants often face a much greater risk of hospitalization due to their developing immune systems and smaller airways. One hundred to 300 children aged less than 5 years die of RSV each year.